What Is Ozempic Used For? Approved Uses Explained

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This guide lives in the PlexusDx Education Hub, where we unpack GLP-1 science, weight-management protocols, and the genetic factors behind metabolic decisions. Open the Education Hub

Getting straight to the question

If you are asking what Ozempic is used for, the useful starting point is knowing exactly what it is. Ozempic is Novo Nordisk's brand of semaglutide, a GLP-1 receptor agonist. Semaglutide is a modified version of native human GLP-1, engineered to resist DPP-4 degradation and deliver sustained receptor engagement at therapeutic doses. This overview covers its approved uses, its mechanism, side effects, and cost, as of April 2026. Open the Education Hub for more.

What Ozempic is approved for

Across the semaglutide brands, the FDA approvals split by product: Ozempic and Rybelsus are approved for type 2 diabetes, while Wegovy carries the chronic weight management approval. That brand-to-indication mapping matters, because the same molecule under a different brand is not automatically interchangeable for insurance or coverage purposes. Prescribing follows the brand's FDA-approved indication.

How the medicine acts

Ozempic engages the GLP-1 receptor in the pancreas, hypothalamus, and gastrointestinal tract, slowing gastric emptying, blunting post-meal glucose excursions, reducing appetite, and increasing satiety signaling. GIP/GLP-1 dual agonists such as tirzepatide additionally engage the GIP receptor for a second incretin mechanism. Dosing that is weekly or daily, depending on the compound, delivers sustained receptor engagement.

Broader class indications for context

To place Ozempic within the wider class: FDA-approved indications include type 2 diabetes for most compounds, chronic weight management for Wegovy, Saxenda, and Zepbound, cardiovascular risk reduction in type 2 diabetes for several products, and obstructive sleep apnea in adults with obesity for Zepbound, added in 2024. Knowing these distinctions helps explain why coverage and eligibility differ so much brand to brand.

Common side effects

Gastrointestinal symptoms, including nausea, vomiting, diarrhea, and constipation, are the most commonly reported effects and are usually most pronounced during dose titration. All FDA-approved GLP-1 compounds carry the class boxed warning for thyroid C-cell tumor risk observed in rodent studies. Rare serious events include pancreatitis, gallbladder disease, and acute kidney injury in the context of dehydration. These are reasons a provider reviews your history and contraindications carefully before prescribing.

Cost and access

Manufacturer list prices for FDA-approved branded products typically range from $800 to $1,600 per month at U.S. list as of April 2026. Your out-of-pocket cost depends on insurance coverage, the FDA indication on the prescription, manufacturer savings card eligibility, and whether a compounded alternative is available through a licensed 503A pharmacy pathway.

Why brand and indication matter for access

Because Ozempic and Wegovy are both semaglutide but carry different approvals, the brand written on your prescription shapes what happens at the pharmacy counter. Insurance coverage, prior authorization, and manufacturer savings card eligibility all key off the FDA indication tied to the specific brand, not the molecule in the abstract. That is why two people prescribed semaglutide can face very different out-of-pocket costs depending on which brand and indication apply. It also underscores why the same molecule under a different brand is not automatically interchangeable for coverage. If cost or availability is your main concern, the practical questions to raise with a provider are which brand fits your clinical situation, which indication your prescription reflects, and whether a compounded pathway through a licensed pharmacy is appropriate for you.

The upstream genetic context

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, including Semaglutide Injection and oral options. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, GLP1R, MC4R, and TCF7L2 that shape baseline appetite and energy balance. It does not predict response to Ozempic or any medication; it provides pathway-level context for a provider conversation.

Frequently Asked Questions

Is Ozempic the same as Wegovy?

Both are Novo Nordisk brands of semaglutide, but they carry different FDA-approved indications. Ozempic is approved for type 2 diabetes, while Wegovy is approved for chronic weight management. Because prescribing follows the brand's specific indication, the two are not automatically interchangeable for insurance or coverage purposes.

How does Ozempic work in the body?

Ozempic engages the GLP-1 receptor to slow gastric emptying, blunt post-meal glucose, reduce appetite, and increase satiety signaling. Weekly dosing sustains that receptor engagement. Effects on weight and A1C vary by dose and individual according to clinical trial data, so your provider tailors the plan to your situation.

What are the most common Ozempic side effects?

Gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation are the most commonly reported, usually strongest during dose titration. The class also carries a boxed warning for thyroid C-cell tumor risk seen in rodent studies, and rare serious events include pancreatitis, gallbladder disease, and acute kidney injury with dehydration.

Can genetics tell me how I will respond to Ozempic?

No. The Precision Peptide Genetic Test does not predict response to Ozempic or any specific medication. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that shape baseline energy-balance biology, offering upstream context you can bring into a conversation with your prescribing provider.

Keep reading across the PlexusDx Education Hub for more evidence-based GLP-1 and metabolic health explainers. Return to the Education Hub

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.